440881003: Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Bexarotene\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)

\Medicinal product\Product manufactured as cutaneous dose form\Product containing bexarotene in cutaneous dose form (medicinal product form)\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing benzoic acid\Product containing only benzoic acid (medicinal product)\Bexarotene\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing benzoic acid\Product containing bexarotene\Bexarotene\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing benzoic acid\Product containing bexarotene\Product containing bexarotene in cutaneous dose form (medicinal product form)\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing bexarotene\Bexarotene\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing naphthalene\Product containing bexarotene\Product containing bexarotene in cutaneous dose form (medicinal product form)\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing terpene\Product containing retinoid\Product containing bexarotene\Bexarotene\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing terpene\Product containing retinoid\Product containing bexarotene\Product containing bexarotene in cutaneous dose form (medicinal product form)\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bexarotene\Bexarotene\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bexarotene\Product containing bexarotene in cutaneous dose form (medicinal product form)\Product containing only bexarotene in cutaneous dose form (medicinal product form)\Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

4596581012 Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

4596582017 Bexarotene 10 mg/g cutaneous gel en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Is a	Product containing bexarotene in topical dosage form	false	Inferred relationship	Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has active ingredient	Bexarotene	false	Inferred relationship	Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	Cutaneous AND/OR transdermal dosage form	false	Inferred relationship	Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	Conventional release cutaneous gel	true	Inferred relationship	Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Is a	TEMPORARY parent for CDs that are not updated	false	Inferred relationship	Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator unit	milligram	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator value	10	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has precise active ingredient	Bexarotene	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has basis of strength substance	Bexarotene	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Is a	Product containing only bexarotene in cutaneous dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator unit	microgram	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator unit	gram	true	Inferred relationship	Existential restriction modifier	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4596581012	Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
4596582017	Bexarotene 10 mg/g cutaneous gel	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module